<DOC>
	<DOCNO>NCT00195390</DOCNO>
	<brief_summary>The purpose study identify follow problem question respect safety Pneumococcal 7-Valent Conjugate Vaccine ( Diphtheria CRM 197 Protein ) , Prevenar , post-marketing period Korea , require Korea Food Drug Administration ( KFDA ) regulation . 1 . Adverse reaction ( especially serious adverse reaction ) 2 . Incidences adverse reaction routine vaccine use 3 . Factors may affect safety vaccine</brief_summary>
	<brief_title>Study Investigating Administration Prevenar Post-Marketing Surveillance</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Infants child age 6 week 9 year , provide condition pertain contraindication , warning , precaution , interaction state package insert apply . Hypersensitivity latex component vaccine , include diphtheria toxoid Suffering current recent febrile illness .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>heptavalent pneumococcal conjugate vaccine</keyword>
</DOC>